BRPI0817396A2 - Método para tratar deficiência de vitamina b12 num indivíduo e composição farmacêutica para tratar deficiência de vitamina b12 num individuo - Google Patents

Método para tratar deficiência de vitamina b12 num indivíduo e composição farmacêutica para tratar deficiência de vitamina b12 num individuo

Info

Publication number: BRPI0817396A2
Authority: BR; Brazil
Prior art keywords: deficiency; individual; treating vitamin; pharmaceutical composition; vitamin
Prior art date: 2007-11-02

Application number

Other languages

English (en)

Inventor

Cristina Castelli

Original Assignee

Emisphere Tech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-02

Filing date

2008-10-31

Publication date

2015-04-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0817396(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-31 Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc

2015-04-07 Publication of BRPI0817396A2 publication Critical patent/BRPI0817396A2/pt

2019-04-24 Publication of BRPI0817396B1 publication Critical patent/BRPI0817396B1/pt

2020-02-04 Publication of BRPI0817396B8 publication Critical patent/BRPI0817396B8/pt

2020-11-17 Publication of BRPI0817396C1 publication Critical patent/BRPI0817396C1/pt

2021-05-25 Publication of BRPI0817396C8 publication Critical patent/BRPI0817396C8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0817396A 2007-11-02 2008-10-31 composição farmacêutica para tratar deficiência de vitamina b¹² BRPI0817396C8 (pt)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US98489807P	2007-11-02	2007-11-02
US60/984,898		2007-11-02
US2010808P	2008-01-09	2008-01-09
US61/020,108		2008-01-09
US8356608P	2008-07-25	2008-07-25
US61/083,566		2008-07-25
PCT/US2008/082064 WO2009059188A1 (en)	2007-11-02	2008-10-31	Method of treating vitamin b12 deficiency

Publications (5)

Publication Number	Publication Date
BRPI0817396A2 true BRPI0817396A2 (pt)	2015-04-07
BRPI0817396B1 BRPI0817396B1 (pt)	2019-04-24
BRPI0817396B8 BRPI0817396B8 (pt)	2020-02-04
BRPI0817396C1 BRPI0817396C1 (pt)	2020-11-17
BRPI0817396C8 BRPI0817396C8 (pt)	2021-05-25

Family

ID=40591491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817396A BRPI0817396C8 (pt)	2007-11-02	2008-10-31	composição farmacêutica para tratar deficiência de vitamina b¹²

Country Status (18)

Country	Link
US (3)	US8022048B2 (pt)
EP (1)	EP2215047B1 (pt)
JP (1)	JP5555634B2 (pt)
KR (1)	KR101344369B1 (pt)
CN (1)	CN101952241B (pt)
AU (1)	AU2008318423B2 (pt)
BR (1)	BRPI0817396C8 (pt)
CA (1)	CA2704780C (pt)
CL (1)	CL2010000434A1 (pt)
CO (1)	CO6280475A2 (pt)
DK (1)	DK2215047T3 (pt)
ES (1)	ES2443817T3 (pt)
MX (1)	MX2010004716A (pt)
NZ (1)	NZ585080A (pt)
PL (1)	PL2215047T3 (pt)
PT (1)	PT2215047E (pt)
RU (1)	RU2469728C2 (pt)
WO (1)	WO2009059188A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5985985B2 (ja) *	2009-08-03	2016-09-06	エミスフィアーテクノロジーズインコーポレイテッドＥｍｉｓｐｈｅｒｅＴｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ．	胃腸への影響が減少した即効型ナプロキセン組成物
MX2012009914A (es) *	2010-02-24	2013-03-05	Emisphere Tech Inc	Terapia oral de b12.
RS60321B1 (sr)	2010-12-16	2020-07-31	Novo Nordisk As	Čvrste kompozicije koje sadrže glp-1 agonist i so n-(8-(2- hidroksibenzoil)amino)kaprilne kiseline
RU2602601C2 (ru)	2011-04-12	2016-11-20	Ново Нордиск А/С	Дважды ацилированные производные glp-1
US8805208B2 (en) *	2012-02-03	2014-08-12	Tyco Electronics Subsea Communications Llc	System and method for polarization de-multiplexing in a coherent optical receiver
LT2827885T (lt)	2012-03-22	2018-10-10	Novo Nordisk A/S	Glp-1 peptidų kompozicijos ir jų gavimas
DK2827845T3 (en)	2012-03-22	2019-04-01	Novo Nordisk As	COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF
CN111494323B (zh)	2012-03-22	2023-03-28	诺和诺德股份有限公司	包含递送剂的组合物及其制备
ES2871328T3 (es)	2012-06-20	2021-10-28	Novo Nordisk As	Formulación de comprimido que comprende un péptido y un agente de suministro
US20170348417A1 (en)	2013-04-11	2017-12-07	Richard Louis Price	Treatment of attention deficit disorders and associated symptoms
US10098848B2 (en)	2013-04-11	2018-10-16	Richard Louis Price	Inositol-containing comestible units and methods of treatment using the same
US9211284B2 (en)	2013-04-11	2015-12-15	Richard Louis Price	Diagnosis and treatment of P.R.I.C.E. syndrome
US20140309270A1 (en)	2013-04-11	2014-10-16	Richard Louis Price	Diagnosis and treatment of a form of autistic spectrum disorder
US9603812B2 (en)	2013-04-11	2017-03-28	Richard Louis Price	Treatment of autistic spectrum disorder
RU2671406C2 (ru)	2013-05-02	2018-10-31	Ново Нордиск А/С	Пероральная дозированная форма соединений глюкагоноподобного пептида-1
CN109069475B (zh)	2016-04-22	2022-01-28	受体控股公司	快速作用植物类医药化合物和营养补剂
EA201892396A1 (ru)	2016-12-02	2019-04-30	Ресептор Лайф Сайенсиз, Инк.	Быстродействующие растительные лекарственные соединения и биологически активные добавки
AU2018345812A1 (en) *	2017-10-05	2020-05-14	Spoke Sciences, Inc.	Herbal compositions with improved bioavailability
US20200254041A1 (en) *	2017-10-05	2020-08-13	Receptor Holdings, Inc.	Rapid onset and extended action plant-based and synthetic cannabinoid formulations
HUE063787T2 (hu)	2018-02-02	2024-01-28	Novo Nordisk As	Egy GLP-1 agonistát, egy N-(8-(2-hidroxibenzoil)amino) kaprilsav sót és egy síkosítóanyagot tartalmazó szilárd készítmények
WO2020106767A1 (en)	2018-11-19	2020-05-28	Receptor Holdings, Inc.	N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5665379A (en)	1990-09-28	1997-09-09	Pharmacia & Upjohn Aktiebolag	Lipid particle forming matrix, preparation and use thereof
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US5650386A (en)	1995-03-31	1997-07-22	Emisphere Technologies, Inc.	Compositions for oral delivery of active agents
WO1998011900A2 (en) *	1996-09-18	1998-03-26	Sarill William J	Compositions containing cobalamin and amino acids
US5773647A (en)	1997-02-07	1998-06-30	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
ES2268900T3 (es) *	1998-12-28	2007-03-16	Cobalis Corp.	Tratamiento con cianocobalamina (vitamina b12) de las enfermedades alergicas.
EP1535625B1 (en)	1999-04-05	2014-01-08	Novartis AG	Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin
CA2369591C (en) *	1999-04-05	2011-06-14	Emisphere Technologies, Inc.	Disodium salts, monohydrate, and ethanol solvates
ATE554062T1 (de)	2000-03-21	2012-05-15	Emisphere Tech Inc	Verfahren zur herstellung von alkylierten salicylamiden durch ein dicarboxylat- zwischenprodukt
US7049283B2 (en)	2000-12-06	2006-05-23	Novartis Ag	Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ATE356631T1 (de)	2001-06-01	2007-04-15	Novartis Pharma Gmbh	Orale verabreichung von parathyroidhormon und calcitonin
WO2003015822A1 (en)	2001-08-17	2003-02-27	Novartis Ag	5-cnac as oral delivery agent for parathyroid hormone fragments
US20050054557A1 (en)	2002-05-09	2005-03-10	Goldberg Michael M.	Compositions for delivering parathyroid hormone and calcitonin
TW200403052A (en)	2002-07-17	2004-03-01	Novartis Ag	Use of organic compounds
TWI307279B (en)	2002-08-01	2009-03-11	Novartis Ag	Oral administration of calcitonin
CN100344328C (zh)	2002-09-13	2007-10-24	锡德克斯公司	以衍生环糊精稳定化的含有水性填充组合物的胶囊
CN100579955C (zh)	2003-04-04	2010-01-13	帝斯曼知识产权资产管理有限公司	N-烷氧基草酰丙氨酸酯的制备方法
US6938439B2 (en)	2003-05-22	2005-09-06	Cool Clean Technologies, Inc.	System for use of land fills and recyclable materials
JP3924616B2 (ja)	2003-06-30	2007-06-06	独立行政法人物質・材料研究機構	微小サイズの温度感知素子を用いる温度計測方法
KR20060105735A (ko)	2003-07-04	2006-10-11	니코메드 덴마크 에이피에스	경구용 부갑상선 호르몬 함유 약학 조성물
WO2005004900A1 (en)	2003-07-11	2005-01-20	Novartis Ag	Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
WO2005014031A1 (en)	2003-07-23	2005-02-17	Novartis Ag	Use of calcitonin in osteoarthritis
BRPI0510231A (pt) *	2004-05-06	2007-10-30	Emisphere Tech Inc	composto, polimorfo cristalino, cossolvato em metanol e água, cossolvato em metanol-água, cossolvato em etanol-água, composição farmacêutica, método para administrar um agente ativo, método para preparar a forma i do snac, método para preparar a forma ii de snac, método para preparar a forma iii de snac, método para preparar a forma iv de snac, método para preparar a forma v de snac, método para preparar a forma vi de snac, composição farmacêutica e método para preparar snac amorfo
EP1773354A4 (en) *	2004-08-02	2010-05-05	Bebaas Inc	COMPOSITIONS OF VITAMIN B12
WO2006124047A2 (en)	2004-08-13	2006-11-23	Emisphere Technologies, Inc.	Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US20060116334A1 (en) *	2004-12-01	2006-06-01	Curt Hendrix	Folate based composition for treatment of the cardiovascular system
GB0427600D0 (en)	2004-12-16	2005-01-19	Novartis Ag	Organic compounds
GB0427603D0 (en)	2004-12-16	2005-01-19	Novartis Ag	Organic compounds
CN101296694A (zh)	2005-11-04	2008-10-29	真塔公司	药物镓组合物和方法

2008
- 2008-10-31 MX MX2010004716A patent/MX2010004716A/es active IP Right Grant
- 2008-10-31 US US12/262,677 patent/US8022048B2/en not_active Expired - Fee Related
- 2008-10-31 JP JP2010532292A patent/JP5555634B2/ja not_active Expired - Fee Related
- 2008-10-31 WO PCT/US2008/082064 patent/WO2009059188A1/en not_active Ceased
- 2008-10-31 ES ES08844673.7T patent/ES2443817T3/es active Active
- 2008-10-31 KR KR1020107010771A patent/KR101344369B1/ko not_active Expired - Fee Related
- 2008-10-31 DK DK08844673.7T patent/DK2215047T3/da active
- 2008-10-31 AU AU2008318423A patent/AU2008318423B2/en not_active Ceased
- 2008-10-31 BR BRPI0817396A patent/BRPI0817396C8/pt not_active IP Right Cessation
- 2008-10-31 CA CA2704780A patent/CA2704780C/en not_active Expired - Fee Related
- 2008-10-31 PL PL08844673T patent/PL2215047T3/pl unknown
- 2008-10-31 EP EP08844673.7A patent/EP2215047B1/en not_active Not-in-force
- 2008-10-31 CN CN200880119724.0A patent/CN101952241B/zh not_active Expired - Fee Related
- 2008-10-31 RU RU2010118423/15A patent/RU2469728C2/ru active
- 2008-10-31 NZ NZ585080A patent/NZ585080A/en not_active IP Right Cessation
- 2008-10-31 PT PT88446737T patent/PT2215047E/pt unknown
2010
- 2010-04-30 CL CL2010000434A patent/CL2010000434A1/es unknown
- 2010-06-02 CO CO10066425A patent/CO6280475A2/es active IP Right Grant
2011
- 2011-08-09 US US13/206,090 patent/US8288360B2/en not_active Expired - Fee Related
2012
- 2012-09-14 US US13/618,654 patent/US8557792B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2215047B1 (en)	2013-11-20
US20100016255A1 (en)	2010-01-21
EP2215047A1 (en)	2010-08-11
WO2009059188A1 (en)	2009-05-07
CO6280475A2 (es)	2011-05-20
CL2010000434A1 (es)	2011-01-28
BRPI0817396B8 (pt)	2020-02-04
PL2215047T3 (pl)	2014-05-30
AU2008318423A1 (en)	2009-05-07
RU2469728C2 (ru)	2012-12-20
US8288360B2 (en)	2012-10-16
EP2215047A4 (en)	2010-11-10
BRPI0817396C1 (pt)	2020-11-17
NZ585080A (en)	2012-05-25
KR101344369B1 (ko)	2013-12-24
JP2011502997A (ja)	2011-01-27
DK2215047T3 (da)	2014-02-03
ES2443817T3 (es)	2014-02-20
MX2010004716A (es)	2010-12-17
AU2008318423B2 (en)	2013-12-05
US20110293589A1 (en)	2011-12-01
US8022048B2 (en)	2011-09-20
CN101952241A (zh)	2011-01-19
US20130040910A1 (en)	2013-02-14
CA2704780A1 (en)	2009-05-07
RU2010118423A (ru)	2011-12-10
HK1146480A1 (en)	2011-06-10
BRPI0817396C8 (pt)	2021-05-25
KR20100126263A (ko)	2010-12-01
US8557792B2 (en)	2013-10-15
CA2704780C (en)	2014-06-10
JP5555634B2 (ja)	2014-07-23
BRPI0817396B1 (pt)	2019-04-24
CN101952241B (zh)	2014-06-11
PT2215047E (pt)	2014-01-20

Publication	Publication Date	Title
BRPI0817396A2 (pt)	2015-04-07	Método para tratar deficiência de vitamina b12 num indivíduo e composição farmacêutica para tratar deficiência de vitamina b12 num individuo
BRPI0811589A2 (pt)	2014-10-29	Composição farmacêutica e método para tratar câncer
BRPI0809655A2 (pt)	2014-10-07	Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit
BRPI0810806A2 (pt)	2014-10-29	Método para tratar uma lesão cutânea em um indivíduo
BRPI0812425A2 (pt)	2014-12-02	Sistema vertical para o tratamento de metalização de uma peça de trabalho e método para transporte da peça de trabalho
BRPI0908637A2 (pt)	2018-10-23	composto; composição farmacêutica do mesmo e método para inibição de proliferação celular em um indivíduo.
BRPI0816009A2 (pt)	2018-07-31	método e aparelho de administração de colisões em transmissões de e-dch comuns.
BRPI0813429A2 (pt)	2017-02-21	sistema e método para uma mbms aperfeiçoada para uma transferência de pss
BRPI0819075A2 (pt)	2014-10-07	Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
BRPI0917358A2 (pt)	2015-11-17	formulação farmacêutica de liberação controlada e método.
BRPI0720604A8 (pt)	2017-02-21	composição e método para detecção de desmineralização
BRPI0906804A2 (pt)	2015-07-14	Método para liofilizar partículas, e, acondicionamento farmacêutico
BRPI0811059A2 (pt)	2017-05-09	combinação, composição farmacêutica, método para tratar câncer em um animal de sangue quente, e, uso de uma combinação
BR112012008854A2 (pt)	2015-09-22	combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
BRPI0807918A2 (pt)	2017-05-16	composições e método para preservação de tecido
BRPI0813725A2 (pt)	2014-12-30	Métodos e composições para tratamento de doenças
BRPI0818011A2 (pt)	2015-04-14	Método e dispositivo para associar objetos
BRPI0918496A2 (pt)	2019-09-24	composto inibidor bicíclico de quinase, uso do mesmo, composição farmacêutica e método para inibir a atividade da quinase pim em uma célula
PT2178796T (pt)	2021-03-29	Método contínuo para tratamento de líquidos e fabrico de certos constituintes
BRPI0909164A2 (pt)	2016-06-21	método e composições para o tratamento de câncer
BRPI0821679A2 (pt)	2015-06-16	Método e aparelho para auto-recuperação transparente em redes de cadeia e anel
BRPI0914023A2 (pt)	2016-07-26	composição nutricional e método para fornecer uma nutrição
BRPI0913280A2 (pt)	2016-07-26	dispositivo e método para o tratamento de fluxos de artigos
HUP0700369D0 (en)	2007-07-30	Pharmaceutical compositions and method for treating schizofrenia
HU0700370D0 (en)	2007-07-30	Pharmaceutical compositions and method for treating acuse mania

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-05-08	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-06-05	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2018-09-25	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-02-12	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-04-24	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/04/2019, OBSERVADAS AS CONDICOES LEGAIS
2020-02-04	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: REF. RPI 2520 DE 25/04/2019 QUANTO AO INVENTOR.
2020-11-17	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: REF. RPI 2520 DE 24/04/2019 QUANTO AO PRAZO DE VALIDADE.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2023-08-22	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2023-12-12	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2746 DE 22-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.